Incannex Healthcare Inc. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
Incannex Healthcare Inc. (IXHL) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of $0.17 per share as of 2021-06-30, per its 20-F filed 2022-10-28.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2022-10-28
- 2021-06-30: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $0.17.
- 2020-06-30: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $0.10.
- 2019-06-30: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $0.04.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2021-06-30 | $0.17 20-F · filed 2022-10-28 |
| 2020-06-30 | $0.10 20-F · filed 2022-10-28 |
| 2019-06-30 | $0.04 20-F · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |